HK1107018A1 - Use of alpha-ketoglutarate and related compounds for lowering plasma lipids - Google Patents

Use of alpha-ketoglutarate and related compounds for lowering plasma lipids

Info

Publication number
HK1107018A1
HK1107018A1 HK08100710.1A HK08100710A HK1107018A1 HK 1107018 A1 HK1107018 A1 HK 1107018A1 HK 08100710 A HK08100710 A HK 08100710A HK 1107018 A1 HK1107018 A1 HK 1107018A1
Authority
HK
Hong Kong
Prior art keywords
ketoglutarate
alpha
related compounds
plasma lipids
lowering plasma
Prior art date
Application number
HK08100710.1A
Other languages
English (en)
Inventor
Stefan Pierzynowski
Radoslaw Piotr Radzki
Marek Bienko
Original Assignee
Sgp & Sons Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sgp & Sons Ab filed Critical Sgp & Sons Ab
Publication of HK1107018A1 publication Critical patent/HK1107018A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/03—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Fodder In General (AREA)
HK08100710.1A 2004-06-17 2008-01-18 Use of alpha-ketoglutarate and related compounds for lowering plasma lipids HK1107018A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PL04368572A PL368572A1 (en) 2004-06-17 2004-06-17 Pharmaceutical compound for prevention and therapy of increased level of cholesterol, ldl and triglycerides as well as application of the pharmaceutical compound as an agent acting against atherosclerosis and used in circulatory system affections
PCT/SE2005/000929 WO2005123056A1 (en) 2004-06-17 2005-06-16 Use of alpha-ketoglutarate and related compounds for lowering plasma lipids

Publications (1)

Publication Number Publication Date
HK1107018A1 true HK1107018A1 (en) 2008-03-28

Family

ID=35509438

Family Applications (1)

Application Number Title Priority Date Filing Date
HK08100710.1A HK1107018A1 (en) 2004-06-17 2008-01-18 Use of alpha-ketoglutarate and related compounds for lowering plasma lipids

Country Status (11)

Country Link
US (1) US20080027139A1 (ko)
EP (1) EP1755580A1 (ko)
JP (1) JP4927721B2 (ko)
KR (1) KR101212583B1 (ko)
CN (1) CN101001620B (ko)
AU (1) AU2005253914B2 (ko)
CA (1) CA2568902A1 (ko)
HK (1) HK1107018A1 (ko)
PL (1) PL368572A1 (ko)
RU (1) RU2375055C2 (ko)
WO (1) WO2005123056A1 (ko)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL226695B1 (pl) * 2006-07-03 2017-08-31 Danuta Kruszewska Środek do zastosowania w zapobieganiu i/lub hamowaniu kolonizacji Helicobacter pylori, zastosowanie soli kwasu alfa‑ketoglutarowego z metalami alkalicznymi i ziem alkalicznych do wytwarzania środka leczniczego oraz dodatku do żywności do zapobiegania i/lub hamowania kolonizacji Helicobacter pylori
BRPI0814184A2 (pt) * 2007-07-02 2015-03-03 Entress Ab Uso de compostos químicos farmacologicamente ativos conhecidos
CN102014888A (zh) * 2007-07-03 2011-04-13 达努塔·克鲁谢夫斯卡 α-酮戊二酸的新医药用途
JP4996527B2 (ja) * 2008-04-14 2012-08-08 日本特殊陶業株式会社 積層型ガスセンサ素子及びガスセンサ
CN105076722A (zh) * 2015-08-26 2015-11-25 中国科学院亚热带农业生态研究所 a-酮戊二酸二钠在制备家禽饲料中的应用
CN105029086A (zh) * 2015-08-26 2015-11-11 中国科学院亚热带农业生态研究所 a-酮戊二酸二钠在制备猪饲料中的应用
CN105029087A (zh) * 2015-08-26 2015-11-11 中国科学院亚热带农业生态研究所 a-酮戊二酸二钾在制备猪饲料中的应用
CN107412216B (zh) * 2017-07-26 2020-08-07 华南农业大学 α-酮戊二酸在改善高脂饮食导致的动物繁殖功能损伤方面的应用
CN112955139A (zh) 2018-09-25 2021-06-11 庞塞迪利昂健康特定活动公司 用于制备α-酮戊二酸钙的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3542929A (en) * 1966-02-23 1970-11-24 Hope City Chemotherapeutic compositions useful in animal detoxification
SE9303691D0 (sv) * 1993-11-09 1993-11-09 Gramineer Ab New beverage
WO1998033494A1 (en) * 1997-02-04 1998-08-06 Kosbab John V Compositions and methods for prevention and treatment of vascular degenerative diseases
US6277431B1 (en) * 1998-10-14 2001-08-21 Redeem, Inc. Anticholesterolemic edible oil

Also Published As

Publication number Publication date
US20080027139A1 (en) 2008-01-31
AU2005253914A1 (en) 2005-12-29
PL368572A1 (en) 2005-12-27
EP1755580A1 (en) 2007-02-28
CN101001620A (zh) 2007-07-18
KR20070040371A (ko) 2007-04-16
JP4927721B2 (ja) 2012-05-09
AU2005253914B2 (en) 2011-06-30
CN101001620B (zh) 2010-06-16
RU2006143803A (ru) 2008-07-27
KR101212583B1 (ko) 2012-12-14
WO2005123056A1 (en) 2005-12-29
CA2568902A1 (en) 2005-12-29
JP2008502679A (ja) 2008-01-31
RU2375055C2 (ru) 2009-12-10

Similar Documents

Publication Publication Date Title
HK1107018A1 (en) Use of alpha-ketoglutarate and related compounds for lowering plasma lipids
IL212985A0 (en) Therapeutic uses of inhibitors of rtp801
AP2870A (en) Odcase inhibitors for the treatment of malaria
HK1119696A1 (en) Pyridopyrimidinone inhibitors of pi3k pi3k
HK1199254A1 (en) Process for the preparation of aurora kinase inhibitors
SG119330A1 (en) Improved shirttails for reducing damaging effects of cuttings
EP1756092A4 (en) NEW INHIBITORS OF RHO-KINASEN
EP2026843A4 (en) THERAPEUTIC USES OF RTP801L INHIBITORS
IL190292A0 (en) PYRIDOPYRIMIDINONE INHIBITORS OF P13Ka
EP1718611A4 (en) 3-3-DI-SUBSTITUTED OXINDOLES AS INHIBITORS OF INITIATION OF TRANSLATION
IL196956A0 (en) Aza-benzofuranyl compounds and methods of use
ZA200704106B (en) Inhibitors of c-fms kinase
SG152225A1 (en) Inhibitors of iap
IL179854A0 (en) Inhibitors of iap
ZA200706345B (en) Amino-pyridines as inhibitors of ß-secretase
IL211835A0 (en) Therapeutic uses of inhibitors of rtp801
TWI341695B (en) Method for controlling volume of earphone
IL197060A0 (en) Aza-benzothiophenyl compounds and methods of use
IL182735A0 (en) Inhibitors of c-fms kinase
ZA200900896B (en) Aza-benzofuranyl compounds and methods of use
EP1934196A4 (en) CYTOTOXIN COMPOUNDS AND METHODS OF ISOLATION
ZA200804266B (en) Therapeutic uses of steroidal compounds
ZA200901009B (en) Aza-benzothiophenyl compounds and methods of use
SI2035379T1 (sl) Inhibitorji 11-beta-hidroksisteroid dehidrogeneaze 1
AU2005906584A0 (en) Use of Inhibitors of Prolyl-4-Hydroxylases

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20140616